Jump to content
Content on WikiMesothelioma is reviewed prior to publication by three named attorneys at Danziger & De Llano LLP. Dr. Luciano Mutti, MD, PhD, co-author of the European mesothelioma treatment guidelines, serves as the site's Medical Reviewer. See our editorial standards.

Johns-Manville Trust

From WikiMesothelioma — Mesothelioma Knowledge Base
(Redirected from Johns Manville Trust)


Manville Personal Injury Settlement Trust
Asbestos personal injury trust for Johns-Manville Corporation (verified 2026-10-08)
Current pro rata payment percentage 5.6% of a claim's liquidated value (raised from 5.1%; notice posted September 3, 2026)[1]
Mesothelioma Scheduled Value $350,000 (Level VIII)[2]
Mesothelioma Maximum Value $750,000 (individual evaluation ceiling, except Extraordinary Claims)[2]
Bankruptcy filed August 1982, Chapter 11[3]
Trust operational November 28, 1988[3]
Claims liquidated 1,041,171, totaling $5,343,613,806 (through June 30, 2026)[4]
Cash equivalents and investments $632,971,774 (June 30, 2026)[4]
Claims administrator Claims Resolution Management Corporation (CRMC)[5]
🛡️ Check Your Eligibility
📞 (855) 699-5441

Executive Summary

The Manville Personal Injury Settlement Trust, usually called the Johns Manville Trust or the Manville Trust, pays asbestos personal injury claims against Johns-Manville Corporation. Johns-Manville filed for reorganization under Chapter 11 in August 1982, and the U.S. Court of Appeals for the Second Circuit confirmed its Plan of Reorganization on October 28, 1988. The trust became operational thirty days later, on November 28, 1988.[3]

The trust values claims under its Trust Distribution Process (TDP), which offers a fixed Scheduled Value for each of eight Scheduled Diseases, $350,000 for mesothelioma, or an individual evaluation capped at a Maximum Value, $750,000 for mesothelioma, except for Extraordinary Claims.[2] The trust then pays a pro rata share of that value. On September 3, 2026, the trust's administrator posted that the pro rata payment percentage had been raised from 5.1% to 5.6%, "effective immediately".[1]

Through June 30, 2026, the trust had liquidated 1,041,171 claims totaling $5,343,613,806, and it held $632,971,774 in cash equivalents and investments.[4]

At a Glance

Johns Manville Trust at a glance:

  • 5.6% pro rata payment percentage, raised from 5.1% in a notice posted September 3, 2026[1]
  • $350,000 mesothelioma Scheduled Value (Level VIII), the amount the trust offers when a claim meets the mesothelioma criteria[2]
  • $19,600: the pro rata payment on a $350,000 Scheduled Value at 5.6%, before any attorney's fee[2][1]
  • $750,000 mesothelioma Maximum Value for an individually evaluated claim, unless the trust treats it as an Extraordinary Claim[2]
  • Eight Scheduled Diseases, from Other Asbestos Disease (Level I) to Mesothelioma (Level VIII)[2]
  • First-in, first-out: claims are processed and paid in FIFO order, with exceptions for Exigent Health and Extreme Hardship claims[2]
  • 1,041,171 claims liquidated through June 30, 2026, totaling $5,343,613,806[4]
  • Attorneys' fees capped at 25% of what the trust actually pays, where the fee is a percentage of recovery[2]

Key Facts: Johns Manville Trust

Metric Finding
Bankruptcy filing August 1982, Chapter 11, which suspended all personal injury lawsuits against Johns-Manville[3]
Plan confirmed October 28, 1988, by the U.S. Court of Appeals for the Second Circuit[3]
Trust operational November 28, 1988[3]
Governing document 2002 Trust Distribution Process, May 2021 Revision[2]
Current payment percentage 5.6% of liquidated value, effective September 2026[1]
Initial payment percentage 10%, when the TDP took effect in February 1995[4]
Mesothelioma Scheduled Value $350,000[2]
Mesothelioma Maximum Value $750,000[2]
Claims liquidated 1,041,171 through June 30, 2026, totaling $5,343,613,806, an average of $5,132[4]
Cash equivalents and investments $632,971,774 at June 30, 2026[4]
Net claimants' equity $570,516,505 at June 30, 2026[4]
Claims administrator Claims Resolution Management Corporation (CRMC)[5]


⚠ Statute of Limitations Warning: Every state sets its own filing deadline for asbestos claims, and some are as short as one year. The date the deadline starts to run also differs by state and is not always the date of diagnosis. Contact an attorney immediately to preserve your rights.

How Does the Trust Distribution Process Value a Claim?

The Manville Trust's Trust Distribution Process (TDP) is the document that sets how a claim is valued and paid. The version the trust publishes today is the "2002 Trust Distribution Process, May 2021 Revision." The TDP states its goal as treating "all claimants equitably," and it does that in two steps: it first fixes a claim's liquidated value, then pays a pro rata share of that value.[2] For a plain-language walk-through of filing, see the Johns Manville Trust claims guide on Mesothelioma Lawyers Near Me.

Step 1: Scheduled Value or individual evaluation

When a claim reaches its turn in the first-in, first-out (FIFO) queue, the trust checks it against the Categorization Criteria for eight Scheduled Diseases. If the claim qualifies, the trust offers the Scheduled Value for that disease, together with a release. A claimant who accepts and returns the signed release is paid within 30 days, subject to the trust's payment limits.[2]

Level Scheduled Disease Scheduled Value Maximum Value
I Other Asbestos Disease (Cash Discount Payment) $600 $600[2]
II Asbestosis/Pleural Disease $12,000 $30,000[2]
III Asbestosis/Pleural Disease $25,000 $40,000[2]
IV Severe Asbestosis Disease $95,000 $400,000[2]
V Other Cancer $45,000 $200,000[2]
VI Lung Cancer (One) None $50,000[2]
VII Lung Cancer (Two) $95,000 $400,000[2]
VIII Mesothelioma $350,000 $750,000[2]

Source: 2002 Manville TDP, May 2021 Revision, Section D and Attachment A.[2]

For mesothelioma (Level VIII), the criteria are a diagnosis of mesothelioma and "credible evidence of exposure to Manville asbestos products prior to December 31, 1982".[2]

A claimant can instead elect individual evaluation, including a claimant whose claim did not fit a Scheduled Disease. The TDP warns that individual evaluation is "costly and time-consuming, resulting in significant delay in claim payment," and that the trust will not value a claim above its Scheduled Value "unless a higher value is clearly justified." If the final individual offer comes in lower than the Scheduled Value, the claimant cannot go back to the earlier Scheduled Value offer.[2] Individual evaluations weigh the factors the TDP lists, including disease, age, settlements and verdicts in the claimant's jurisdiction, Manville's market share, whether the claimant is living or dead, disability, dependency, special damages, and pain and suffering.[2]

An individually evaluated claim is capped at the Maximum Value for its disease category. The TDP says the Maximum Value "will only be offered to those claimants who present the most severe combinations of factors to be anticipated within the category." The cap can be exceeded only for an Extraordinary Claim, for example where the claimant "was exposed only to Manville asbestos products" or where Manville products were "the overwhelming majority" of the exposure.[2]

Step 2: The pro rata share

Whatever the liquidated value, whether a Scheduled Value, an individual evaluation, an arbitration award or a court judgment, the claimant receives only a pro rata share of it. The share is set by the trust with the concurrence of the Selected Counsel for the Beneficiaries and the Legal Representative of Future Claimants, and it "may be adjusted upwards or downwards from time to time." The TDP adds: "no guaranty can be made of any pro rata share of a claim's liquidated value".[2]

At the 5.6% payment percentage the trust adopted in September 2026, a mesothelioma claim paid at the $350,000 Scheduled Value receives $19,600.[2][1] The TDP caps attorneys' fees at 25%, measured on what the trust actually pays rather than on the liquidated value.[2]

The trust's June 2026 court filing shows the pro rata system at scale. For claims after the 1990 class action complaint, the trust made offers at a full liquidated amount of $55,549,724,410, and the pro rata reduction brought the net offers to $4,293,124,262.[4]

What limits payment timing

The TDP adds three timing limits:

  • FIFO order. A claim's queue position is the earlier of the date the trust receives an acceptable proof of claim or the date a lawsuit was filed. Claims are paid in the order they are liquidated.[2]
  • Exigent Health and Extreme Hardship. The trust may process and pay these claims outside FIFO order. For living claimants with confirmed mesothelioma, the TDP irrebuttably presumes substantial medical doubt that they will survive beyond six months, so they qualify for Exigent Health treatment if they settle their Trust claim.[2]
  • Maximum Annual Payment. Each year the trust models its cash flow, and its distributions to all claimants for that year "shall not exceed the Maximum Annual Payment".[2] The trust added this provision to the 2002 TDP in January 2012.[4]

Can You File Both a Trust Claim and a Lawsuit?

The TDP connects a Manville Trust claim and the tort system in several places. A lawsuit for an asbestos-related injury against the trust or any other defendant counts toward a claim's place in line: FIFO position runs from the earlier of the trust's receipt of an acceptable proof of claim or the filing of such a lawsuit.[2] For a claim that fits a Scheduled Disease and is supported by appropriate evidence, the trust "will not dispute the culpability of Manville's conduct" and may contest only matters such as the claimant's injuries, exposure to Manville products, other causation-in-fact issues, damages and the statute of limitations.[2]

A claimant who rejects a non-binding arbitration award may return to the tort system. A judgment is paid from Pool A only up to the Maximum Value for its disease category. The excess goes to Pool B, which receives no funds until every Pool A claim has been paid 50% of its liquidated value. The TDP says: "It is doubtful that Pool B will ever be funded".[2]

2026 Trust Status Update

On September 3, 2026, the trust's administrator posted that the pro rata payment percentage had been raised from 5.1% to 5.6%, effective immediately. From September 2, the e-Claims system set 5.6% on all future offers and re-issued outstanding offers at 5.6%. The administrator also said it had "identified claims by law firm that are eligible for a retroactive supplemental payment adjustment" and planned to issue those payments in mid-October.[1] As of November 7, 2026, the administrator's Manville announcements showed no later notice confirming that the payments had been issued.[6]

The trust's most recent quarterly filing reports, as of June 30, 2026, cash equivalents and investments of $632,971,774 and net claimants' equity of $570,516,505.[4]

What Is the Future Outlook for the Johns Manville Trust?

The trust's court filings describe it as a "limited fund": the courts adopted a finding that there is a substantial probability its estimated future assets will be insufficient to pay all claims in full. The trust forecasts its cash until the last projected future claim and sets the payment percentage so that it will have no remaining assets or liabilities after the last future claimant receives a pro rata share.[4] The TDP requires the trust to re-estimate its assets and liabilities at least every three years and decide whether a revised percentage should apply.[2] Because future claims and assets are difficult to predict, the TDP says "no guaranty can be made of any pro rata share of a claim's liquidated value".[2]

How Has the Payment Percentage Changed?

The trust paid its early claims at 100% of settlement value.[3] After a class action filed in 1990, the court approved a settlement in January 1995, and the trust implemented the TDP payment procedures on February 21, 1995, with an initial 10% payment percentage.[4] The trust's own court filings record each change since:

When Change
February 1995 TDP payment procedures take effect at 10%[4]
June 2001 Reduced from 10% to 5%[4]
August 2002 2002 TDP adopted, principally changing categorization criteria and scheduled values[4]
March 2008 Raised from 5% to 7.5%[4]
January 2012 Maximum Annual Payment provision added to the 2002 TDP[4]
August 2014 Reduced from 7.5% to 6.25%[4]
November 2016 Reduced from 6.25% to 5.1%[4]
April 28, 2020 Reduced from 5.1% to 4.3%[4]
February 15, 2021 Raised from 4.3% to 5.1%[4]
September 2026 Raised from 5.1% to 5.6%[1]

When the percentage rises, the TDP provides for catch-up payments to earlier claimants paid at a lower share, though it says such payments to claimants who have already received 10% are "increasingly unlikely".[2] For how this change compares with other trusts in 2026, see Johns Manville Trust 2026 on Mesothelioma Lawyers Near Me.

Which Occupations Had the Highest Johns Manville Exposure?

The TDP does not rank occupations. Every claim must show exposure to an asbestos-containing product produced by Manville before December 31, 1982, and some disease levels add a requirement of "Significant Occupational Exposure." The TDP defines that as employment for a cumulative period of at least five years in an industry and occupation in which the claimant:[2]

  • handled raw asbestos fibers on a regular basis;
  • fabricated asbestos-containing products and was regularly exposed to raw fibers in the process;
  • altered, repaired or otherwise worked with an asbestos-containing product and was regularly exposed to fibers; or
  • worked regularly in close proximity to workers doing any of those things.

Exposure can be shown by the claimant's affidavit, a co-worker's affidavit, a family member's affidavit for a deceased claimant, invoices, construction or similar records, or other credible evidence.[2] For the company and its products, see Johns-Manville_Corporate_History.

How Do You File a Claim with the Johns Manville Trust?

A claim begins with a proof of claim form filed with the trust, and its FIFO position runs from the date the trust receives an acceptable form or the date of an earlier asbestos lawsuit.[2] The TDP's evidence rules shape what a claim needs:

  • Medical evidence. A malignant disease (Levels V to VIII) must be diagnosed either on a physical examination by the diagnosing physician or by a board-certified pathologist. Every diagnosis must also show at least 10 years between first asbestos exposure and diagnosis.[2]
  • Exposure evidence. Every Disease Level requires exposure to an asbestos-containing product produced by Manville before December 31, 1982.[2]
  • Secondary exposure. A claimant exposed through an occupationally exposed person, such as a family member, must have the claim individually reviewed and must show that the other person would have met the TDP's exposure requirements.[2]
  • Filing deadline. Under an amendment effective January 1, 2011, a claim for exposure in the United States must meet the federal or state statute of limitations in effect when it is filed with the trust. In addition, "irrespective of the application of any relevant federal or state statute of limitations or repose," any claim may be filed within three years after the date of diagnosis or, if later, the date of asbestos-related death. Claims for exposure outside the United States must be filed within that three-year window.[2][7]

After an offer, a claimant has 360 days to respond before the claim is deactivated, and a claimant may ask to defer processing for up to three years while keeping the original FIFO place.[2] The trust's documents page posts the TDP, proof of claim forms and filing instructions.

Frequently Asked Questions

What is the Johns Manville Trust's payment percentage?

5.6%. The trust's administrator posted on September 3, 2026 that the Trustees, with the concurrence of the Selected Counsel for the Beneficiaries and the Legal Representative of Future Claimants, approved an increase from 5.1% to 5.6%, effective immediately.[1]

How much does the Johns Manville Trust pay for mesothelioma?

The TDP sets a $350,000 Scheduled Value for mesothelioma. At the 5.6% payment percentage, that is a payment of $19,600, before any attorney's fee. A claimant who elects individual evaluation may receive a value higher or lower than the Scheduled Value, up to the $750,000 Maximum Value unless the claim qualifies as an Extraordinary Claim.[2][1]

What is the Manville Trust Distribution Process?

It is the trust's rulebook for valuing and paying claims. The current version is the 2002 Trust Distribution Process, May 2021 Revision. It sets the eight Scheduled Diseases and their values, the individual evaluation route, the pro rata payment share, FIFO processing, and the Maximum Annual Payment.[2]

Who can file a Johns Manville Trust claim?

A person with one of the TDP's Scheduled Diseases, or another compensable asbestos-related disease, who can show exposure to a Manville asbestos-containing product before December 31, 1982. Secondary exposure claims, such as exposure through a family member's work, are individually reviewed.[2]

Can a claim be filed for someone who has died?

Yes. The TDP sets diagnosis rules for claimants who were deceased when the claim was filed, and it lists whether the claimant is living or dead among the factors in an individual evaluation.[2]

How fast does the trust pay?

After a claimant accepts an offer and returns the signed release, the TDP calls for payment within 30 days. Payments can be delayed when the trust lacks available funds or reaches its Maximum Annual Payment for the year.[2]

Will the trust run out of money?

The trust sets its payment percentage so that it will have no remaining assets or liabilities after the last future claimant receives a pro rata share. The courts found that the trust is a "limited fund".[4] The TDP says no guaranty can be made of any pro rata share.[2]

Quick Statistics

  • 5.6%: pro rata payment percentage since September 2026[1]
  • $350,000: mesothelioma Scheduled Value[2]
  • $750,000: mesothelioma Maximum Value[2]
  • 1,041,171: claims liquidated through June 30, 2026[4]
  • $5,132: average amount per liquidated claim through June 30, 2026[4]
  • $632,971,774: cash equivalents and investments at June 30, 2026[4]

References and Citations

  1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Claims Resolution Management Corporation, "Manville: Increase in the pro rata payment percentage", posted September 3, 2026: the Trustees, "with the concurrence of the Selected Counsel for the Beneficiaries ('SCB') and the Legal Representative of Future Claimants ('Legal Representative'), have approved effective immediately, an increase in the pro rata payment percentage from 5.1% to 5.6%." Retrieved October 8, 2026.
  2. ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 2.35 2.36 2.37 2.38 2.39 2.40 2.41 2.42 2.43 2.44 2.45 2.46 2.47 2.48 2.49 2.50 2.51 2.52 2.53 2.54 2002 Trust Distribution Process, May 2021 Revision, Manville Personal Injury Settlement Trust. Overview (Section A), FIFO ordering and categorization (B), individual evaluation, Maximum Values, Extraordinary Claims, Exigent Health and Secondary Exposure (C), Schedule of Asbestos-Related Disease Categories and Values (D), evidentiary requirements (E), the two pools (G), pro rata share, order of payment and Maximum Annual Payment (H), attorneys' fees (J), and Attachment A, Maximum Values. Retrieved October 8, 2026.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 History, Manville Personal Injury Settlement Trust. August 1982 Chapter 11 filing, October 28, 1988 Second Circuit confirmation, November 28, 1988 start of operations, and early payments at 100% of settlement value. Retrieved October 8, 2026.
  4. ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 Financial Statements and Report of Manville Personal Injury Settlement Trust for the Period Ending June 30, 2026, In re Johns-Manville Corporation, Case Nos. 82 B 11656 through 82 B 11676 (Bankr. S.D.N.Y.), Doc 4480, filed July 27, 2026. Statement of net claimants' equity, Note 6 (Net Claimants' Equity, payment percentage history) and Exhibit III (Supplemental Schedule of Liquidated Claims). Retrieved October 8, 2026.
  5. ↑ 5.0 5.1 Manville Personal Injury Settlement Trust, home page, naming Claims Resolution Management Corporation (CRMC) as the trust's claims processor. Retrieved October 8, 2026.
  6. ↑ Claims Resolution Management Corporation, "Manville" announcements, accessed November 7, 2026: the newest Manville post listed is the September 3, 2026 payment-percentage notice.
  7. ↑ "Manville Trust Distribution Process Revised: Statute of Limitations Provision Modified", Manville Personal Injury Settlement Trust: the January 2010 amendment requiring that claims be filed before applicable statutes of limitations expire, effective January 1, 2011. Retrieved October 8, 2026.